ropinirole 0.25 MG Oral Tablet
INDICATIONS & USAGE Parkinson’s Disease Ropinirole Tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. The effectiveness of Ropinirole Tablets were demonstrated in randomized, controlled trials in patients with early Parkinson’s disease who were not receiving concomitant L-dopa therapy as well as in patients with advanced disease on concomitant L-dopa (see CLINICAL PHARMACOLOGY: Clinical Trials). Restless Legs Syndrome Ropinirole Tablets are indicated for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS). Key diagnostic criteria for RLS are: an urge to move the legs usually accompanied or caused by uncomfortable and unpleasant leg sensations; symptoms begin or worsen during periods of rest or inactivity such as lying or sitting; symptoms are partially or totally relieved by movement such as walking or stretching at least as long as the activity continues; and symptoms are worse or occur only in the evening or night. Difficulty falling asleep may frequently be associated with moderate-to-severe RLS.
Alembic Pharmaceuticals Limited
ROUND WHITE H 121
H 121 ROUND WHITE
Related Pills
ropinirole hydrochloride 1 mg
Alembic Pharmaceuticals Limited
ropinirole 0.5 MG Oral Tablet
alembic pharmaceuticals limited
ropinirole 3 MG Oral Tablet
alembic pharmaceuticals limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Tablets Each circular, biconvex, film-coated tablet contains ropinirole as follows: 0.25 mg: white tablets debossed with “H” on one side and “121” on other side NDC 46708-030-30 bottle of 30 tablets NDC 46708-030-31 bottle of 100 tablets 0.5 mg: yellow tablets debossed with “H” on one side and “122” on other side NDC 46708-031-30 bottle of 30 tablets NDC 46708-031-31 bottle of 100 tablets 1 mg: green tablets debossed with “H” on one side and “123” on other side NDC 46708-032-30 bottle of 30 tablets NDC 46708-032-31 bottle of 100 tablets 2 mg: peach tablets debossed with “H” on one side and “124” on other side NDC 46708-033-30 bottle of 30 tablets NDC 46708-033-31 bottle of 100 tablets 3 mg: purple tablets debossed with “H” on one side and “125” on other side NDC 46708-034-30 bottle of 30 tablets NDC 46708-034-31 bottle of 100 tablets 4 mg: Pale brown tablets debossed with “H” on one side and “126” on other side NDC 46708-035-30 bottle of 30 tablets NDC 46708-035-31 bottle of 100 tablets 5 mg: blue tablets debossed with “H” on one side and “127” on other side NDC 46708-036-30 bottle of 30 tablets NDC 46708-036-31 bottle of 100 tablets STORAGE: Protect from light and moisture. Close container tightly after each use. Store at controlled room temperature 20°-25°C (68°-77°F) [see USP]. Manufactured by: Alembic Pharmaceuticals Limited (Formulation Division), Village Panelav, P. O. Tajpura, Near Baska, Taluka-Halol, Panchmahal, Gujarat, India. Revision Date: 09/2019
More pills like ROUND H 121